e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Respiratory medicine meets rheumatology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is it a connective tissue disease? Antibody patterns that the pulmonologist should be aware of
D. Kyburz (Basel, Switzerland)
Source:
International Congress 2018 – Respiratory medicine meets rheumatology
Session:
Respiratory medicine meets rheumatology
Session type:
Symposium
Number:
5140
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Kyburz (Basel, Switzerland). Is it a connective tissue disease? Antibody patterns that the pulmonologist should be aware of. International Congress 2018 – Respiratory medicine meets rheumatology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Kada Bentata - 01.08.2019 12:00
Very useful conference for daily practice
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
From life threatening to chronic connective tissue disease-associated interstitial lung disease: all you need to know
Source: Virtual Congress 2020 – From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know
Year: 2020
Significance of connective tissue disease in a typical UK diffuse parenchymal lung disease clinic
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Lung involvement and clinical characteristics in anti-MDA5 positive connective tissue diseases
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Myositis-associated interstitial pneumonia (MaIP): Autoantibody associations in patients presenting to pulmonologists and rheumatologists
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Non Specific Interstitial Pneumonia and features of connective tissue disease:what are the consequences of a different point of view?
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren's syndrome
Source: Eur Respir Rev 2009; 19: 161-163
Year: 2010
Choosing pharmacotherapy for ILD in patients with connective tissue disease
Source: Breathe, 17 (4) 210114; 10.1183/20734735.0114-2021
Year: 2021
What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Distance assessment of the risk of pulmonary hypertension associated with connective tissue diseases: do biomarkers help?
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Subclinical ILD is frequent and progresses across different connective tissue diseases
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Case-based imaging of connective tissue disease-related lung disease
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021
The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=1
Year: 2005
Heritable connective tissue disorders as factor modifying asthma symptoms in pediatric patients
Source: Annual Congress 2012 - Asthma management
Year: 2012
Clinical analysis of lung manifestation in Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Pulmonary involvement in children with rheumatic diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept